SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is experiencing significant volatility as the community debates whether the stock is primed for a short squeeze driven by pending peptide regulatory updates and a potential partnership with Eli Lilly. Investors are closely monitoring the company's aggressive growth in GLP-1 distribution and app store rankings, contrasting these fundamental catalysts against persistent concerns over insider selling and broad market macro pressures.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as the community closely monitors its pending acquisition of Northern Data and the substantial financial backing from Tether, which has led to significant debate regarding a potential short squeeze given the elevated short interest and limited tradeable float. Investors are heavily focused on the company's expanding AI and cloud infrastructure capabilities, viewing these strategic developments as a catalyst for future valuation growth.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is surging as investors react to the SEC's plan to eliminate the $25,000 pattern day trading rule, a move that is expected to significantly boost platform volume and retail engagement. The community is actively discussing the stock's potential for a short squeeze and long-term recovery, fueled by the termination of a dilutive financing agreement and increased market optimism for fintech brokerage firms.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing intense volatility as investors react to Amazon's agreement to acquire Globalstar, prompting debate over whether this represents a competitive threat or validation of the satellite-to-phone sector. Despite the price pullback, the community remains divided between those bracing for further downside due to repeated launch delays and those aggressively buying the dip in anticipation of the upcoming BlueBird 7 mission.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is seeing significant momentum driven by a combination of new defense contracts and high-profile industry validation, fueling intense debate between bullish traders eyeing a potential short squeeze and skeptics wary of the company's high cash burn and valuation. The stock is currently a major focal point for retail investors who are tracking bullish options flow and active sector rotation into quantum computing stocks.

Xanadu Quantum Technologies Ltd. engages in the provision of quantum computing solutions for enterprise and government customers. The company was founded by Christian Weedbrook on October 2, 2025 and is headquartered in Toronto, Canada.

Xanadu Quantum Technologies Ltd. - Ordinary Shares - Class B (Sub Voting)

Xanadu Quantum Technologies is attracting significant investor attention as a pure-play photonic quantum computing company following its recent public debut. The community is actively debating the potential for a short squeeze driven by a low float and high borrow rates, while others focus on its strategic partnerships with major industry leaders.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is seeing intense investor debate as the stock faces continued underperformance relative to major indices, leading to friction between shareholders expecting growth and those advocating for capital preservation. The conversation is dominated by frustration over the company's massive cash pile, skepticism regarding the leadership transition to Greg Abel, and mixed reactions to the resumption of share buybacks.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum Inc. is trending as investors weigh recent analyst price target adjustments against broader sector volatility, while community discourse remains heavily divided between long-term optimism over the company's dual-platform strategy and deep skepticism regarding its path to profitability. The stock remains a focal point for traders debating the balance between speculative quantum hype and the impact of competing breakthroughs from major tech incumbents.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood Markets (HOOD) is seeing a surge in investor interest and volume following the SEC's approval to eliminate the Pattern Day Trader (PDT) rule, a major regulatory shift that lowers barriers for retail day trading. The community is actively debating the stock's potential for a short squeeze toward the $100 level, with many users highlighting how this rule change could significantly boost transaction-based revenue and retail engagement on the platform.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSM is trending as investors aggressively position themselves ahead of the upcoming earnings report, with significant call flow activity suggesting strong bullish sentiment despite ongoing geopolitical concerns regarding chip production and energy supply. The community is actively debating the company's long-term manufacturing moat against competitors and monitoring potential supply chain bottlenecks in AI-critical materials.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TVTX Stock Soars on FDA Nod for Filspari in Second Kidney Indication

Travere Therapeutics stock jumps 37% after the FDA expands Filspari's use to a second rare kidney disease, boosting its market reach and treatment potential.

NVO Inks Deal With OpenAI for Speedy Drug Discovery Globally, Stock Up

Novo Nordisk stock up as it teams up with OpenAI to deploy AI across drug discovery and operations, aiming to speed therapies, boost efficiency and counter rising competition.

CGON Stock Up 60.8% in Six Months: Here's What You Need to Know

CG Oncology stock surges as early phase III data, strong bladder cancer results and a $900M cash cushion fuel rising investor confidence.

Does Catalyst (CPRX) Have the Potential to Rally 28.87% as Wall Street Analysts Expect?

The mean of analysts' price targets for Catalyst (CPRX) points to a 28.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

Kymera Therapeutics shares jump after FDA grants Fast Track to KT-621 for eosinophilic asthma, spotlighting its first-in-class STAT6 degrader potential.

RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data

Revolution Medicines jumps 41% as phase III data show daraxonrasib boosts survival in metastatic PDAC, paving the way for global regulatory filings.

ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study

Allogene jumps as cema-cel shows strong MRD clearance and safety in the ALPHA3 study, signaling potential in first-line LBCL treatment.

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

REPL stock plunges after a second FDA CRL delays RP1 melanoma approval, casting doubt on its regulatory path and near-term growth plans.

SNY & REGN's Dupixent Gets EU Approval for Pediatric Use in Urticaria 

Sanofi wins EC nod to expand Dupixent use to children aged 2 to 11 years with CSU, backed by phase III data, marking the first targeted option in the EU.

SG Americas Securities LLC Has $765,000 Stock Position in Catalyst Pharmaceuticals, Inc. $CPRX

SG Americas Securities LLC lowered its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 60.8% in the fourth quarter, according to its most recent disclosure with...

Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.

Current Price	$25.93
Prev Close	$26.19
Open	$26.05
Dividend Yield	0.00%
50-Day Moving Average	$24.25
Beta	0.99
Avg. Volume	1.19M
PE Ratio	15.55

52-Week High	$26.58
52-Week Low	$19.05
Market Capitalization	$3.2B
EPS (Annual)	$1.68
Price to Book	3.36
Revenue Per Employee	$3.24M

CPRX
Catalyst Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CPRX News

CPRXCatalyst Pharmaceuticals Inc